Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Digital Diabetes Management Market Revenue Growth Supported By A CAGR Of 58.13% Through 2030
The digital management of diabetes has witnessed substantial expansion, projecting a rise from $19.19 billion in 2025 to $23.99 billion by 2026, reflecting a robust compound annual growth rate of 25.0%. This upward trajectory in the historical period is underpinned by several key factors, including the escalating global prevalence of diabetes, the constrained availability of consistent clinical oversight, a surge in smartphone adoption, a growing appetite for tools enabling personal health monitoring, and the broader proliferation of digital health services.
The digital diabetes management sector is poised for remarkable expansion, projected to reach a substantial $58.13 billion by the year 2030, exhibiting a compound annual growth rate of 24.8%. This anticipated surge is fueled by several key factors including the escalating integration of artificial intelligence within diabetes care protocols, the broadening scope of remote patient monitoring solutions, growing acceptance of telehealth services, seamless incorporation with electronic health records, and a heightened demand for tailored diabetes management approaches. Dominant trends expected to shape this market during the forecast period encompass the swift embrace of remote diabetes monitoring platforms, the incorporation of AI-driven glucose analytics, the proliferation of mobile applications dedicated to diabetes management, a surge in the utilization of wearable devices for diabetes tracking, and the increasing prevalence of telemedicine in delivering diabetes care.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3414&type=smp
#Digital Diabetes Management Market Growth Drivers And Industry Catalysts
The escalating global occurrence of diabetes is poised to fuel expansion within the digital diabetes care sector. Diabetes, a metabolic disorder marked by persistently high blood sugar, predominantly the type 2 form that compromises the body’s insulin functionality, is becoming more widespread. This surge in diabetes cases is largely attributable to rising obesity rates, which substantially elevate insulin resistance and consequently augment the likelihood of developing type 2 diabetes. Consequently, the digital diabetes management field is experiencing heightened interest as the rapid proliferation of diabetes compels organizations to implement contemporary solutions such as remote health tracking, mobile application-based monitoring, and tailored virtual guidance to empower individuals in their self-care efforts. As an illustration, in June 2024, NHS England reported a sharp upswing, of almost 25% within the preceding year, in the number of individuals under 40 identified as having risks for type 2 diabetes, escalating from 173,166 in 2022 to 216,440 in 2023. Consequently, the growing incidence of diabetes is a significant factor contributing to the increasing demand for the digital diabetes management market.
Digital Diabetes Management Market Segments: Where Are The Largest Growth Opportunities?
The digital diabetes management market covered in this report is segmented –
1) By Product And Service: Devices, Application, Data Management Software And Platforms, Services
2) By Device Type: Handheld Devices, Wearable Devices
3) By End User: Self Or Home Healthcare, Hospitals And Specialty Diabetes Clinics, Other End Users
Subsegments:
1) By Devices: Continuous Glucose Monitors (CGMs), Blood Glucose Meters (BGM), Insulin Pumps, Smart Insulin Pens, Diabetes Testing Strips
2) By Application: Diabetes Management Apps, Lifestyle And Diet Management Apps, Glucose Tracking Apps, Insulin Dose Adjustment Apps, Exercise And Activity Tracking Apps
3) By Data Management Software And Platforms: Cloud-Based Diabetes Management Platforms, Data Analytics Platforms, Electronic Health Record (EHR) Integrated Systems, Patient Management Software, Remote Monitoring Software
4) By Services: Telemedicine And Virtual Consultation Services, Remote Monitoring Services, Diabetes Education Services, Diabetes Coaching And Support Services, Clinical Decision Support Services
#Digital Diabetes Management Market Trends Influencing Long-Term Demand
Key players within the digital diabetes management sector are prioritizing the creation of sophisticated technologies, including implantable continuous glucose monitoring (CGM) devices designed for prolonged use. These innovations aim to alleviate the challenges faced by patients, elevate the precision of real-time glucose tracking, and ultimately refine the comprehensive management of diabetes. The concept of long-term implantable CGM entails devices inserted subcutaneously that meticulously track glucose levels over extended durations, furnishing dependable data without the recurring need for sensor changes, a distinct advantage over conventional, shorter-acting CGM sensors. A noteworthy development occurred in September 2024 when Senseonics Holdings, Inc., a medical technology firm based in the United States, secured FDA approval for Eversense 365, which stands as the inaugural fully implantable CGM sensor globally boasting a full year of functionality. This system, intended for individuals aged 18 and above diagnosed with type 1 or type 2 diabetes, disseminates glucose measurements every five minutes to a mobile application, necessitates only weekly calibration post the initial two-week period, and incorporates a detachable transmitter. Such an extended-duration solution significantly curtails disruptions to daily life, reduces the frequency of sensor disposals, and facilitates seamless incorporation with automated insulin delivery (AID) platforms, thereby presenting a more integrated and precise methodology for managing diabetes digitally.
Digital Diabetes Management Market Major Participants And Competitive Dynamics
Major companies operating in the digital diabetes management market are Bayer AG, Medtronic Plc, Roche Diagnostics Ltd., Dexcom Inc., Abbott Laboratories, Ascensia Diabetes Care Holdings AG, Insulet Corporation, B. Braun Melsungen AG, Tandem Diabetes Care Inc., LifeScan Inc., AgaMatrix Inc., Glooko Inc., DarioHealth Corp, One Drop, Dottli Oy, Ypsomed Holding AG, ARKRAY Inc., ACON Laboratories Inc., Becton, Dickinson and Company, Care Innovations LLC, Health2Sync Inc., Emperra GmbH E-Health Technologies, Azumio Inc., Decide Clinical Software GmbH, pendiq GmbH Moers, Health Arx Technologies Pvt Ltd., Sanofi SA, Johnson & Johnson Co, Novo Nordisk AS, Terumo Corporation, TidePool, AgaMatrix Medical Devices Ltd.
Access The Complete Digital Diabetes Management Market Report:
https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report
Digital Diabetes Management Market Geographic Distribution And Regional Opportunities
North Americawas the largest region in the digital diabetes management market in 2025. Western Europewas the second largest region in the digital diabetes management market report. The regions covered in the digital diabetes management market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
